Cargando…
Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review
BACKGROUND: There is no consensus on the preferred method for defining the non-inferiority margin in non-inferiority trials, and previous studies showed that the rationale for its choice is often not reported. This study investigated how the non-inferiority margin is defined in the published literat...
Autores principales: | Althunian, Turki A., de Boer, Anthonius, Klungel, Olaf H., Insani, Widya N., Groenwold, Rolf H. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341347/ https://www.ncbi.nlm.nih.gov/pubmed/28270184 http://dx.doi.org/10.1186/s13063-017-1859-x |
Ejemplares similares
-
Defining the noninferiority margin and analysing noninferiority: An overview
por: Althunian, Turki A., et al.
Publicado: (2017) -
Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study
por: Althunian, Turki A., et al.
Publicado: (2020) -
Amiodarone use and the risk of acute pancreatitis: Influence of different exposure definitions
por: Hempenius, Mirjam, et al.
Publicado: (2019) -
Drug exposure misclassification in pharmacoepidemiology: Sources and relative impact
por: Hempenius, Mirjam, et al.
Publicado: (2021) -
Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery
por: Wangge, Grace, et al.
Publicado: (2011)